Removal of the chloroform treatment step from the manufacturing process.
Device | STAARVISC II, SHELLGEL AND COEASE |
Classification Name | Aid, Surgical, Viscoelastic |
Generic Name | Aid, Surgical, Viscoelastic |
Applicant | Anika Therapeutics, Inc. |
Date Received | 2006-01-03 |
Decision Date | 2006-01-24 |
PMA | P000046 |
Supplement | S013 |
Product Code | LZP |
Advisory Committee | Ophthalmic |
Supplement Type | 30-day Notice |
Supplement Reason | Process Change - Manufacturer/sterilizer/packager/supplier |
Expedited Review | No |
Combination Product | No |
Applicant Address | Anika Therapeutics, Inc. 32 Wiggins Avenue bedford, MA 01730 |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P000046 | | Original Filing |
S030 |
2021-11-23 |
Normal 180 Day Track No User Fee |
S029 |
2021-07-29 |
Normal 180 Day Track No User Fee |
S028 |
2021-05-04 |
30-day Notice |
S027 |
2019-05-24 |
Real-time Process |
S026 |
2017-02-14 |
Normal 180 Day Track No User Fee |
S025 |
2014-06-10 |
30-day Notice |
S024 |
2014-06-02 |
30-day Notice |
S023 |
2014-01-15 |
Normal 180 Day Track No User Fee |
S022 |
2013-12-27 |
30-day Notice |
S021 |
2013-12-26 |
30-day Notice |
S020 |
2011-11-04 |
30-day Notice |
S019 |
2010-11-01 |
Normal 180 Day Track No User Fee |
S018 |
2010-11-03 |
30-day Notice |
S017 |
2010-09-30 |
Normal 180 Day Track No User Fee |
S016 |
2009-10-02 |
Normal 180 Day Track No User Fee |
S015 |
2009-05-27 |
Normal 180 Day Track |
S014 |
2006-07-24 |
30-day Notice |
S013 |
2006-01-03 |
30-day Notice |
S012 |
2005-09-07 |
Special (immediate Track) |
S011 |
2005-07-07 |
Special (immediate Track) |
S010 |
2004-06-17 |
30-day Notice |
S009 |
2004-05-07 |
30-day Notice |
S008 |
2003-04-25 |
30-day Notice |
S007 |
2002-11-27 |
Normal 180 Day Track |
S006 |
2002-10-15 |
Normal 180 Day Track |
S005 | | |
S004 |
2002-05-21 |
Normal 180 Day Track |
S003 |
2002-04-17 |
Real-time Process |
S002 |
2002-03-18 |
Normal 180 Day Track |
S001 |
2001-05-10 |
Real-time Process |
NIH GUDID Devices